TIRZEPATIDE

Tirzepatide Overview

Originally developed to treat Type 2 Diabetes, Tirzepatide has become one of the most effective medications for weight loss and metabolic improvement. It functions as a dual agonist of the GLP-1 and GIP receptors—activating two hormonal pathways that work together to reduce appetite, boost metabolism, and support sustained fat loss.

Compared to Semaglutide (which only targets GLP-1), Tirzepatide achieved 5–7% greater weight loss in clinical trials. While Retatrutide (a triple agonist) produced similar weight reduction in a shorter time frame (48 weeks vs. Tirzepatide’s 72 weeks), Tirzepatide remains one of the most well-studied and widely used peptide therapies today.

Mechanism of Action

• GLP-1: Suppresses appetite and promotes satiety after meals.

• GIP: Stimulates insulin secretion and improves energy balance via hypothalamic pathways.

Together, these dual mechanisms help control hunger, improve glucose metabolism, and enhance fat oxidation.

Key Benefits

• Average 24.7% weight loss after 72 weeks

• Reduces appetite and cravings

• Enhances satiety and energy regulation

• Promotes fat metabolism and oxidation

• Improves insulin sensitivity and blood sugar control

Possible Side Effects

Common (Mild to Moderate)

(Generally mild and temporary; affected about 25% of users in studies)

• Injection site irritation (redness, itching, or swelling)

• Nausea or vomiting

• Diarrhea or constipation

• Fatigue

• Indigestion (dyspepsia)

• Abdominal pain or burping (sometimes sulfur-like odor)

• Decreased appetite

• Temporary hair thinning

Rare but Serious Risks

• Thyroid C-cell tumors

• Pancreatitis

• Gastroparesis (delayed stomach emptying)

• Hypoglycemia (when used with insulin)

• Gallbladder disease

• Kidney complications from dehydration

• Pulmonary aspiration under anesthesia

⚠️ Always disclose Tirzepatide use before any surgery.

Side Effect Management Tips

• Avoid greasy or fatty foods

• Stay well-hydrated throughout the day

• Stop eating once full (satiety occurs earlier)

• Dose at night to minimize nausea

• Use fiber supplements to prevent constipation

• If side effects are strong, start with a smaller initial dose and increase more gradually (consult staff for a tailored schedule)

Contraindications

Do not use Tirzepatide if you:

• Are pregnant or breastfeeding

• Have a personal or family history of Medullary Thyroid Carcinoma or MEN 2 (Multiple Endocrine Neoplasia)

• Have Type 1 Diabetes, severe gastrointestinal disorders, or diabetic retinopathy

• Are allergic or hypersensitive to Tirzepatide or its ingredients

Titration

Administration

• Inject subcutaneously (under the skin)

• Dose once every 7 days, on the same day each week

• Remain at each dose level for at least 4 weeks before increasing

• If prone to nausea or dizziness, dose at night

If transferring from another GLP-1 peptide, start at 5mg, not 2.5mg.

Recommended Stacks

• AOD-9604 – Boosts fat breakdown and supports appetite control

• Tesamorelin – Targets visceral fat and enhances metabolic balance

• Semax / Selank – Helps manage mood, focus, and appetite adjustments

• NAD+ / MOTS-C – Supports mitochondrial energy and metabolism during calorie deficit

• GHK-Cu – Boosts collagen, skin elasticity, and post-weight-loss recovery

• BPC-157 – Aids gut repair and relieves nausea or digestive upset

• CJC-1295 / Ipamorelin – Preserves muscle and promotes faster metabolic recovery.

Caveat / Disclaimer

• This guide is for educational purposes only and does not replace medical advice.

• Peptides in compounded form are not approved by the FDA or the Philippine DOH for safety, quality, or effectiveness.

• All medications carry risks. Side effects, allergic reactions, or complications may occur.

• Only a licensed healthcare professional can decide if these peptides are safe for you.

• Do not use if you have medical condition or without medical supervision.

• By using these products, you accept that it is provided “as is”, with no guarantee of results, safety, or effectiveness.

• LUMI+ PEPTIDES PH is not responsible for any misuse, side effects, or complications.